Professor Mark Emberton became a non-executive director at UCLH in September 2022. He is currently the Dean of the Faculty of Medical Sciences and a Professor of Interventional Oncology at the Division of Surgery and Interventional Science at University College London. He has been a consultant urologist at UCLH since 1998. Mark is a founding pioneer of Prostate Cancer UK and an advisor to the Macmillan Cancer Care Advisory Board. He is the lead for the British Association of Urological Surgeons Research, Chairman of the Trial Steering Committee NIHR HTA UpStream Trial and a senior investigator for the NIHR.